• TSC 101 for Newly Diagnosed Individuals or Families

    Virtual Event

    The first pre-conference webinar, TSC 101 for Newly Diagnosed Individuals or Families, will take place on Wednesday, April 29, 2026, at 8:00 pm ET, and feature moderator Jennifer McCrave, RN, BSN, CNRN and presenters Raj Rajaraman, MD, MS and Elizabeth Thiele, MD, PhD. This webinar will provide an overview of TSC and the importance of building a strong network of

  • Consensus Guidelines: What You Need to Know

    Virtual Event

    The second pre-conference webinar, Consensus Guidelines: What You Need to Know, will take place on Monday, May 11, 2026, at 1:00 pm ET , and feature moderator Chris Kingswood, MD and presenters Darcy Krueger MD, PhD; and Hope Northrup, MD. This webinar will provide an overview of the latest Consensus Guidelines for the diagnosis, surveillance, and management of TSC. Developed by international

  • Seizure Types in TSC

    Virtual Event

    The third pre-conference webinar, Seizure Types in TSC, will take place on Wednesday, June 3, 2026, at 12:00 pm ET, and will address seizure types across the lifespan. This webinar will feature moderator Shelly Meitzler and presenters Sam Amin, MBCHB, MRCPCH, MSc, PhD and E. Martina Bebin, MD, MPA. REGISTER HERE

  • Genetics Made Simple

    Virtual Event

    The fourth pre-conference webinar, Genetics Made Simple, will take place on Wednesday, June 17, 2026, at 8:00 pm ET, and feature moderator Danielle Nolan, MD and presenter Hope Northrup, MD. This webinar will break down the basics of TSC genetics making it easier to understand how TSC happens, why it varies from person to person, and what this

  • mTOR Inhibitors: Past, Present and Future

    Virtual Event

    The fifth and final pre-conference webinar, mTOR Inhibitors: Past, Present and Future, will take place on Tuesday, June 30, 2026, at 8:00 pm ET, and feature moderator Elizabeth Skufca and presenters David Ritter, MD, PhD and Michael Wong, MD, PhD. This webinar will explore the evolution of mTOR inhibitors in treating TSC, from their discovery to current clinical use in